MedPath

Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)

Conditions
Epileptic Encephalopathy
Registration Number
NCT02603991
Lead Sponsor
Beijing Pins Medical Co., Ltd
Brief Summary

Prospective cohort study on the long-term effectiveness and safety of PINS vagus nerve stimulators for children and adolescent with refractory epilepsy.

Detailed Description

Epileptic encephalopathy is very common in children and adolescent with epilepsy, but there is no data in clinical studies.The aim of this study is to evaluate the efficacy of the long-term vagus nerve stimulation for children and adolescent with epilepsy

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1
Inclusion Criteria
  1. age 4-18
  2. Diagnostic criteria for epilepsia brain disorders
  3. Having tried appropriate anti-epileptic drugs (AEDs) more than 1 year and zt least 6 seizures per month
  4. patients or his(her) families could understand this method and sign the informed consent
  5. Patients with good compliance and could complete postoperative follow-up
Exclusion Criteria
  1. the vagus nerve lesion and damage
  2. patients with progressive neurological diseases, cardiopulmonary anomaly, respiratory system diseases,digestive system diseases
  3. patients'mental state is not stable,
  4. patients with or anesthesia contraindications,such as long-term use of anticoagulation antiplatelet drugs etc.
  5. patients have or need other implantable devices, such as pacemakers,defibrillators, cochlear and spinal nerve root stimulator.
  6. patients due to their own reasons for the need for nuclear magnetic resonance imaging in the future clinical trials
  7. patients have participated in other clinical trials.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The change of the score in Quality of Life in Children with EpilepsyQOLCE Scores at 3,6,9,12,18, 24 month of stimulation
Secondary Outcome Measures
NameTimeMethod
complicationcomplication at 3,6,9,12, 24 month
Respondent rateRespondent rate at 3,6,9,12,24 month
seizure free rateseizure free rate at 3,6,9,12, 24 month

Trial Locations

Locations (1)

Beijing Tiantan Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath